BTK and acute respiratory distress syndrome: Despite such significant differences in ARDS modeling and siRNA delivery to the BTK, in both studies, knockdown led to a significant protective effect and reduction in lung damage, which indicates a significant potential for using siRNA against the BTK as a pathogenetic therapeutic drug against ARDS.